DANIEL PENCHINA

Supporting legislation to require transparent disclosure of ingredients in consumer household and industrial cleaning products on manufacturers product labels and websites. H.R. 2728, Cleaning Product Labeling Act of 2017 Supporting legislation to require transparent disclosure of ingredients in feminine hygiene products on manufacturers product labels. H.R. 2416, Menstrual Products Right to Know Act of 2017

Supporting legislation to require transparent disclosure of ingredients in consumer household and industrial cleaning products on manufacturers product labels and websites. H.R. 2728, Cleaning Product Labeling Act of 2017 Supporting legislation to require transparent disclosure of ingredients in feminine hygiene products on manufacturers product labels. H.R. 2416, Menstrual Products Right to Know Act of 2017

Supporting legislation to require transparent disclosure of ingredients in consumer household and industrial cleaning products on manufacturers product labels and websites. H.R. 2728, Cleaning Product Labeling Act of 2017 Supporting legislation to require transparent disclosure of ingredients in feminine hygiene products on manufacturers product labels. H.R. 2416, Menstrual Products Right to Know Act of 2017

Supporting legislation to require transparent disclosure of ingredients in consumer household and industrial cleaning products on manufacturers product labels and websites. H.R. 2728, Cleaning Product Labeling Act of 2017 Supporting legislation to require transparent disclosure of ingredients in feminine hygiene products on manufacturers product labels. H.R. 2416, Menstrual Products Right to Know Act of 2017

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Prevention Partners contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Prevention Partners contacted Senate offices about preserving the current Design for the Environment program in the EPA. CURRENT LEGISLATIVE PROPOSALS The Breast Cancer Prevention Partners supports H.R. 2728, the Cleaning Product Labeling Act of 2017, which would require the disclosure of ingredients in cleaning products. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Prevention Partners visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Prevention Partners supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Prevention Partners supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Prevention Partners has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. 2/2/2017 LD2 Lobbying Disclosure Report https://lda.congress.gov/LD/forms/ReportDisplay.aspx?t=2&s=1&i=1 3/4 P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Prevention Partners lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Prevention Partners is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors HJ Res 88, Protecting Access to Affordable Retirement Advice Department of Labor fiduciary rulemaking SEC fiduciary rulemaking

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors HJ Res 88, Protecting Access to Affordable Retirement Advice Department of Labor fiduciary rulemaking SEC fiduciary rulemaking

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking Commerce, Justice, Science Appropriations FY 2016 Appropriations bills.

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking Commerce, Justice, Science Appropriations FY 2016 Appropriations bills.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocacy on behalf of gender equity in medical research, including H.R.2101, the Research for All Act; preventative health care, including H.R. 2355, the Women's Preventive Health Awareness Campaign Act; affordable, high-quality child care; and strengthening efforts to fight human trafficking.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Conducted outreach regarding the need for forensic science reform, including the establishment of and support for a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. S. 3259, Forensic Science and Standards Act of 2016. HR. 5795, Forensic Science and Standards Act of 2016. Advocated for appropriations to support the expansion of forensic science research and standard-setting.

Conducted outreach regarding the need for forensic science reform, including the establishment of and support for a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. S. 3259, Forensic Science and Standards Act of 2016. HR. 5795, Forensic Science and Standards Act of 2016. Advocated for appropriations to support the expansion of forensic science research and standard-setting.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Conducted outreach regarding the need for forensic science reform, including the establishment of and support for a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. S. 3259, Forensic Science and Standards Act of 2016. HR. 5795, Forensic Science and Standards Act of 2016. Advocated for appropriations to support the expansion of forensic science research and standard-setting.

Conducted outreach regarding the need for forensic science reform, including the establishment of and support for a federal entity to develop research, establish standards, and oversee conduct in the field of forensic sciences. S. 3259, Forensic Science and Standards Act of 2016. HR. 5795, Forensic Science and Standards Act of 2016. Advocated for appropriations to support the expansion of forensic science research and standard-setting.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products.

Advocating for meaningful reform of the Toxic Substances Control Act, including making improvements to H.R.2576, the TSCA Modernization Act of 2015; S. 697, the Frank R. Lautenberg Chemical Safety for the 21st Century Act; and S.725, the Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act. Working for reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Supporting the Cleaning Product Right to Know Act (H.R. 5205), which requires manufacturers of both consumer household and industrial cleaning products to disclose all intentionally-added ingredients on their product labels and websites.

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

LEGISLATION IN THE 114TH CONGRESS​ S.1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would remove toxins and regulate Personal Care Products and Cosmetics. H.R.2576, TSCA Modernization Act of 2015 The Breast Cancer Fund supports this bill and has been meeting with House and Senate offices to persuade members to take up the bill in the Senate. S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund opposes this legislation without amendments, as it would do little to strengthen the current TSCA law, but continues to work with members of the Senate Committee on Environment and Public Works to improve and strengthen the bill. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund support action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic and personal care product ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund continues to talk with staff from Senate offices about the introduction of legislation in the Senate to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. Lobbying: U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Consumer Product Safety Commission (CPSC), National Institutes of Health (NIH), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Department of (HHS), Office of Science & Technology Policy (OSTP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)

Legislation in the 114th Congress: S. 1014, Personal Care Products Safety Act The Breast Cancer Fund continues to meet with staff from Senator Feinsteins office and other HELP committee offices to encourage legislative action on the issue of safety of Personal Care Products. The Breast Cancer Fund supports action that would effectively regulate Personal Care Products and Cosmetics to protect the health of consumers, workers, and communities. The Breast Cancer Fund also continues to meet with staff from House offices to encourage introduction of legislation in the House to reform the FDAs regulation of cosmetics and personal care product ingredients to prevent the use of chemicals found to have negative health and environmental impacts. S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. S. 821, BPA in Food Packaging Right to Know Act The Breast Cancer Fund continues to meet with staff from Senate offices to encourage legislative action on the issue of bisphenol-A, which has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund supports action that would ban bisphenol-A from the linings of canned food, foods marketed to children, and food storage containers. S. 3412, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 6269, Ban Poisonous Additives Act of 2016 The Breast Cancer Fund supports this legislation that would ban bisphenol-A in food containers and prevent manufacturers from replacing bisphenol-A in food containers with unsafe alternatives because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. H.R. 5205, Cleaning Product Right to Know Act of 2016 The Breast Cancer Fund supports this bill that would require cleaning products to be labeled with all the ingredients contained therein. The Breast Cancer Fund has been meeting with House offices to urge Members to cosponsor the bill, and also with Senate offices to urge Senators to take up the issue in the Senate. HOUSE AND SENATE APPROPRIATIONS The Breast Cancer Fund contacted House and Senate offices about increasing federal funding for the following: Centers for Disease Control and Prevention Programs, National Environmental Public Health Tracking Network Centers for Disease Control and Prevention Programs, Environmental Health Labs Biomonitoring Program National Institute of Environmental Health Sciences (NIEHS) The Breast Cancer Fund contacted Senate offices about preserving the current Design for the Environment program in the EPA. FUTURE LEGISLATIVE PROPOSALS: The Breast Cancer Fund visits Senate offices to support an amendment to the Senate NDAA that directs the Secretary of Defense, in carrying out research, development, test, and evaluation activities with respect to breast cancer, to implement the recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee to prioritize prevention and increase the study of chemical and physical factors in breast cancer (IBCERCC). The Breast Cancer Fund supports ongoing efforts to reintroduce legislation that would compel manufacturers to provide complete and accurate product labeling of chemicals used in consumer products. Such labeling is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. The Breast Cancer Fund supports ongoing efforts to reintroduce legislation in the House that would mandate the testing of chemicals for their health risks- including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. The Breast Cancer Fund supports actions to ensure appropriate definition and regulation of chemicals Generally Recognized as Safe (GRAS). REGULATION AND LEGISLATIVE INTENT: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), the Breast Cancer Fund has also met with members of the FDA management team concerning the FDAs ongoing cosmetics regulation negotiations and the FDAs transparency policies more generally. P.L. 110-314 - The Consumer Product Safety Commission Improvement Act The Breast Cancer Fund lobbied in support of the provision that bans the use of phthalates in the manufacture of childrens toys. We are now monitoring implementation of this law; working on preserving the law's phthalates provision through the legislative and regulatory process; and urging expeditious research and regulatory action as required by the legislation. P.L. 114-182 - The Frank R. Lautenberg Chemical Safety for the 21st Century Act The Breast Cancer Fund is working to support and encourage strong, health-protective implementation of the recently- enacted reform of the Toxic Substances Control Act (TSCA).

Advocating for increased performance rights for musical artists, including support for the Fair Play, Fair Pay Act (H.R. 1733). Oppose H.Con.Res.17 and S. Con Res. 4 (the Local Radio Freedom Act).

Advocating for increased performance rights for musical artists, including support for the Fair Play, Fair Pay Act (H.R. 1733). Oppose H.Con.Res.17 and S. Con Res. 4 (the Local Radio Freedom Act).

Advocating for increased performance rights for musical artists, including support for the Fair Play, Fair Pay Act (H.R. 1733). Oppose H.Con.Res.17 and S. Con Res. 4 (the Local Radio Freedom Act).

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking Commerce, Justice, Science Appropriations FY 2016 Appropriations bills.

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking Commerce, Justice, Science Appropriations FY 2016 Appropriations bills.

H.R. 1090, the Retail Investor Protection Act Supporting a user fee at the SEC to increase examination of investment advisors Department of Labor fiduciary rulemaking SEC fiduciary rulemaking

Advocating for increased performance rights for musical artists, including support for the Fair Play, Fair Pay Act (H.R. 1733). Oppose H.Con.Res.17 and S. Con Res. 4 (the Local Radio Freedom Act).

Advocating for increased performance rights for musical artists, including support for the Fair Play, Fair Pay Act (H.R. 1733). Oppose H.Con.Res.17 and S. Con Res. 4 (the Local Radio Freedom Act).